Gender differences in diet-induced steatotic disease in Cyp2b-null mice
- PMID: 32155178
- PMCID: PMC7064244
- DOI: 10.1371/journal.pone.0229896
Gender differences in diet-induced steatotic disease in Cyp2b-null mice
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease; however, progression to nonalcoholic steatohepatitis (NASH) is associated with most adverse outcomes. CYP2B metabolizes multiple xeno- and endobiotics, and male Cyp2b-null mice are diet-induced obese (DIO) with increased NAFLD. However, the DIO study was not performed long enough to assess progression to NASH. Therefore, to assess the role of Cyp2b in fatty liver disease progression from NAFLD to NASH, we treated wildtype (WT) and Cyp2b-null mice with a normal diet (ND) or choline-deficient, L-amino acid-defined high fat diet (CDAHFD) for 8 weeks and determined metabolic and molecular changes. CDAHFD-fed WT female mice gained more weight and had greater liver and white adipose tissue mass than their Cyp2b-null counterparts; males experienced diet-induced weight loss regardless of genotype. Serum biomarkers of liver injury increased in both CDAHFD-fed female and male mice; however CDAHFD-fed Cyp2b-null females exhibited significantly lower serum ALT, AST, and ASP concentrations compared to WT mice, indicating Cyp2b-null females were protected from liver injury. In both genders, hierarchical clustering of RNA-seq data demonstrates several gene ontologies responded differently in CDAHFD-fed Cyp2b-null mice compared to WT mice (lipid metabolism > fibrosis > inflammation). Oil Red O staining and direct triglycerides measurements confirmed that CDAHFD-fed Cyp2b-null females were protected from NAFLD. CDAHFD-fed Cyp2b-null mice showed equivocal changes in fibrosis with transcriptomic and serum markers suggesting less inflammation due to glucocorticoid-mediated repression of immune responses. In contrast to females, CDAHFD-fed Cyp2b-null males had higher triglyceride levels. Results indicate that female Cyp2b-null mice are protected from NAFLD while male Cyp2b-null mice are more susceptible to NAFLD, with few significant changes in NASH development. This study confirms that increased NAFLD development does not necessarily lead to progressive NASH. Furthermore, it indicates a role for Cyp2b in fatty liver disease that differs based on gender.
Conflict of interest statement
The authors have declared that no competing interests exist
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g001.gif)
![Fig 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g002.gif)
![Fig 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g003.gif)
![Fig 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g004.gif)
![Fig 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g005.gif)
![Fig 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g006.gif)
![Fig 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g007.gif)
![Fig 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g008.gif)
![Fig 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7064244/bin/pone.0229896.g009.gif)
Similar articles
-
Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease.Toxicol Lett. 2020 Oct 10;332:1-6. doi: 10.1016/j.toxlet.2020.06.020. Epub 2020 Jun 21. Toxicol Lett. 2020. PMID: 32579995
-
Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).PLoS One. 2019 Dec 31;14(12):e0226854. doi: 10.1371/journal.pone.0226854. eCollection 2019. PLoS One. 2019. PMID: 31891606 Free PMC article.
-
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.Cells. 2019 Oct 15;8(10):1259. doi: 10.3390/cells8101259. Cells. 2019. PMID: 31619023 Free PMC article. Review.
-
Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis.J Nutr Biochem. 2019 Aug;70:125-137. doi: 10.1016/j.jnutbio.2019.05.004. Epub 2019 May 21. J Nutr Biochem. 2019. PMID: 31202118 Free PMC article.
-
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.World J Gastroenterol. 2016 Nov 28;22(44):9706-9717. doi: 10.3748/wjg.v22.i44.9706. World J Gastroenterol. 2016. PMID: 27956794 Free PMC article. Review.
Cited by
-
Consequences of Amyloid-β Deficiency for the Liver.Adv Sci (Weinh). 2024 May;11(18):e2307734. doi: 10.1002/advs.202307734. Epub 2024 Mar 2. Adv Sci (Weinh). 2024. PMID: 38430535 Free PMC article.
-
Pregnane X receptor knockout mitigates weight gain and hepatic metabolic dysregulation in female C57BL/6 J mice on a long-term high-fat diet.Biomed Pharmacother. 2024 Apr;173:116341. doi: 10.1016/j.biopha.2024.116341. Epub 2024 Feb 29. Biomed Pharmacother. 2024. PMID: 38428309
-
Increased Perfluorooctanesulfonate (PFOS) Toxicity and Accumulation Is Associated with Perturbed Prostaglandin Metabolism and Increased Organic Anion Transport Protein (OATP) Expression.Toxics. 2024 Jan 26;12(2):106. doi: 10.3390/toxics12020106. Toxics. 2024. PMID: 38393201 Free PMC article.
-
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma.iScience. 2023 Oct 30;26(12):108363. doi: 10.1016/j.isci.2023.108363. eCollection 2023 Dec 15. iScience. 2023. PMID: 38034347 Free PMC article. Review.
-
Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease.Am J Pathol. 2024 Jan;194(1):71-84. doi: 10.1016/j.ajpath.2023.09.016. Epub 2023 Nov 3. Am J Pathol. 2024. PMID: 37925018
References
-
- Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23. 10.1002/hep.25762 - DOI - PubMed
-
- Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies. Clinical Gastroenterology and Hepatology. 2015;13(4):643-54.e9. 10.1016/j.cgh.2014.04.014 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases